Literature DB >> 17454830

Prevention of atrial fibrillation after cardiac surgery.

Hakala Tapio1, Halonen Jari, Mäkinen Kimmo, Hartikainen Juha.   

Abstract

Atrial fibrillation is the most common arrhythmia occurring after heart surgery. Its prevalence after coronary artery bypass surgery is 17-33%. Atrial fibrillation requires additional treatment, lengthens hospitalization and increases the overall expenses of cardiac surgery. Atrial fibrillation can cause hemodynamic problems, predispose to congestive heart failure and increase the risk of stroke. Beta-blockers have been shown to effectively prevent atrial fibrillation, and beta-blockers should be a part of the medication of every patient undergoing cardiac surgery, if there are no contraindications. Amiodarone therapy can also be considered for especially high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454830     DOI: 10.1080/14017430601054076

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  5 in total

Review 1.  Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review.

Authors:  Ioanna Koniari; Efstratios Apostolakis; Christina Rogkakou; Nikolaos G Baikoussis; Dimitrios Dougenis
Journal:  J Cardiothorac Surg       Date:  2010-11-30       Impact factor: 1.637

2.  Effect of prophylaxis of magnesium sulfate for reduction of postcardiac surgery arrhythmia: Randomized clinical trial.

Authors:  Bahman Naghipour; Gholamreza Faridaalaee; Kamran Shadvar; Eissa Bilehjani; Ashkan Heyat Khabaz; Solmaz Fakhari
Journal:  Ann Card Anaesth       Date:  2016 Oct-Dec

Review 3.  Does minimal invasive cardiac surgery reduce the incidence of post-operative atrial fibrillation?

Authors:  Maria Maimari; Nikolaos G Baikoussis; Stelios Gaitanakis; Anna Dalipi-Triantafillou; Andreas Katsaros; Charilaos Kantsos; Vasileios Lozos; Konstantinos Triantafillou
Journal:  Ann Card Anaesth       Date:  2020 Jan-Mar

4.  A Randomized, Placebo-Controlled Trial of Omega-3 Fatty Acids for Inhibition of Supraventricular Arrhythmias After Cardiac Surgery: The FISH Trial.

Authors:  Chirag M Sandesara; Mina K Chung; David R Van Wagoner; Thomas A Barringer; Keith Allen; Hassan M Ismail; Bridget Zimmerman; Brian Olshansky
Journal:  J Am Heart Assoc       Date:  2012-06-22       Impact factor: 5.501

5.  Hemodynamically unstable atrial fibrillation after oral contrast dye instillation in a case of Boerhaave's syndrome.

Authors:  Tanmoy Ghatak; Ratender K Singh; Sukhen Samanta
Journal:  Saudi J Anaesth       Date:  2013-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.